$ABCP
AmBase Corp

2020 Q1 Form 10-Q Financial Statement

#000114036120010960 Filed on May 07, 2020

View on sec.gov

Income Statement

Concept 2020 Q1 2019 Q1
Revenue $0.00 $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $1.390M $873.0K
YoY Change 59.22% -37.64%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $1.419M $888.0K
YoY Change 59.8% -40.8%
Operating Profit -$1.419M -$888.0K
YoY Change 59.8%
Interest Expense $2.000K $0.00
YoY Change
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income -$1.417M -$888.0K
YoY Change 59.57% -149.33%
Income Tax $1.000K -$30.00K
% Of Pretax Income
Net Earnings -$1.418M -$858.0K
YoY Change 65.27% -147.56%
Net Earnings / Revenue
Basic Earnings Per Share -$0.03 -$0.02
Diluted Earnings Per Share -$34.81K -$21.06K
COMMON SHARES
Basic Shares Outstanding 40.74M 40.74M
Diluted Shares Outstanding

Balance Sheet

Concept 2020 Q1 2019 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $7.115M $10.62M
YoY Change -33.0% 430.95%
Cash & Equivalents $7.115M $10.62M
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $7.115M $10.62M
YoY Change -33.0% 430.95%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $0.00 $10.74M
YoY Change -100.0% -46.3%
Total Long-Term Assets $5.387M $10.76M
YoY Change -49.93% -46.21%
TOTAL ASSETS
Total Short-Term Assets $7.115M $10.62M
Total Long-Term Assets $5.387M $10.76M
Total Assets $12.50M $21.38M
YoY Change -41.52% -2.83%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $709.0K $426.0K
YoY Change 66.43% -57.4%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $709.0K $426.0K
YoY Change 66.43% -57.4%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities $0.00 $3.672M
YoY Change -100.0% 83.6%
Total Long-Term Liabilities $0.00 $3.672M
YoY Change -100.0% 83.6%
TOTAL LIABILITIES
Total Short-Term Liabilities $709.0K $426.0K
Total Long-Term Liabilities $0.00 $3.672M
Total Liabilities $709.0K $4.098M
YoY Change -82.7% 104.9%
SHAREHOLDERS EQUITY
Retained Earnings -$531.8M
YoY Change
Common Stock $548.8M
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost) $5.168M
YoY Change
Treasury Stock Shares $5.672M
Shareholders Equity $11.79M $17.28M
YoY Change
Total Liabilities & Shareholders Equity $12.50M $21.38M
YoY Change -41.52% -2.83%

Cashflow Statement

Concept 2020 Q1 2019 Q1
OPERATING ACTIVITIES
Net Income -$1.418M -$858.0K
YoY Change 65.27% -147.56%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities $4.264M $9.912M
YoY Change -56.98% -862.46%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities $0.00
YoY Change
Cash From Investing Activities $0.00
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 0.000 470.0K
YoY Change -100.0% -85.31%
NET CHANGE
Cash From Operating Activities 4.264M 9.912M
Cash From Investing Activities 0.000
Cash From Financing Activities 0.000 470.0K
Net Change In Cash 4.264M 10.38M
YoY Change -58.93% 446.42%
FREE CASH FLOW
Cash From Operating Activities $4.264M $9.912M
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2020Q1 dei Amendment Flag
AmendmentFlag
false
CY2020Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2020Q1 dei Document Period End Date
DocumentPeriodEndDate
2020-03-31
CY2020Q1 dei Entity Address State Or Province
EntityAddressStateOrProvince
FL
CY2020Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2020Q1 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2020Q1 dei Entity Registrant Name
EntityRegistrantName
AMBASE CORP
CY2020Q1 dei Entity Central Index Key
EntityCentralIndexKey
0000020639
CY2020Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
40737751
CY2020Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2020
CY2020Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2020Q1 dei Document Type
DocumentType
10-Q
CY2020Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2020Q1 dei Entity Shell Company
EntityShellCompany
false
CY2020Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2020Q1 dei Entity Small Business
EntitySmallBusiness
true
CY2019Q4 us-gaap Accounts Payable And Accrued Liabilities Current And Noncurrent
AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent
414000
CY2020Q1 us-gaap Accounts Payable And Accrued Liabilities Current And Noncurrent
AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent
709000
CY2020Q1 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
548304000
CY2019Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
548304000
CY2019Q4 us-gaap Assets
Assets
13625000
CY2020Q1 us-gaap Assets
Assets
12502000
CY2019Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
10382000
CY2020Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
4264000
CY2018Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
237000
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2851000
CY2020Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
7115000
CY2019Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
10619000
CY2019Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
2851000
CY2020Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
7115000
CY2020Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2019Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2020Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2019Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2020Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
46410000
CY2019Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
46410000
CY2019Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
85000000
CY2020Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
85000000
CY2020Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
40738000
CY2019Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
40738000
CY2020Q1 us-gaap Common Stock Value
CommonStockValue
464000
CY2019Q4 us-gaap Common Stock Value
CommonStockValue
464000
CY2020Q1 us-gaap Cost Of Property Repairs And Maintenance
CostOfPropertyRepairsAndMaintenance
8000
CY2019Q1 us-gaap Cost Of Property Repairs And Maintenance
CostOfPropertyRepairsAndMaintenance
8000
CY2020Q1 us-gaap Costs And Expenses
CostsAndExpenses
1419000
CY2019Q1 us-gaap Costs And Expenses
CostsAndExpenses
888000
CY2020Q1 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
0
CY2019Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
5370000
CY2020Q1 us-gaap Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
57000
CY2020Q1 us-gaap Defined Contribution Plan Employer Matching Contribution Percent Of Match
DefinedContributionPlanEmployerMatchingContributionPercentOfMatch
1
CY2019Q1 us-gaap Defined Contribution Plan Employer Matching Contribution Percent Of Match
DefinedContributionPlanEmployerMatchingContributionPercentOfMatch
0.33
CY2020Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.03
CY2019Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.02
CY2020Q1 us-gaap General Insurance Expense
GeneralInsuranceExpense
43000
CY2019Q1 us-gaap General Insurance Expense
GeneralInsuranceExpense
46000
CY2020Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-1417000
CY2019Q1 us-gaap Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
13000
CY2019Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-888000
CY2019Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-30000
CY2020Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1000
CY2019Q4 us-gaap Income Tax Receivable
IncomeTaxReceivable
5371000
CY2020Q1 us-gaap Income Tax Receivable
IncomeTaxReceivable
5370000
CY2020Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
-5371000
CY2019Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
-10741000
CY2020Q1 us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
0
CY2019Q1 us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
0
CY2019Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
12000
CY2020Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
295000
CY2019Q1 us-gaap Increase Decrease In Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesReceivable
-10742000
CY2020Q1 us-gaap Increase Decrease In Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesReceivable
-5371000
CY2020Q1 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-16000
CY2019Q1 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-16000
CY2020Q1 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
0
CY2019Q1 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
0
CY2019Q1 us-gaap Investment Income Interest
InvestmentIncomeInterest
0
CY2020Q1 us-gaap Investment Income Interest
InvestmentIncomeInterest
2000
CY2020Q1 us-gaap Labor And Related Expense
LaborAndRelatedExpense
419000
CY2019Q1 us-gaap Labor And Related Expense
LaborAndRelatedExpense
343000
CY2019Q4 us-gaap Liabilities
Liabilities
414000
CY2020Q1 us-gaap Liabilities
Liabilities
709000
CY2020Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
12502000
CY2019Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
13625000
CY2019Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
9912000
CY2020Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
4264000
CY2020Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
0
CY2019Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
470000
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
-1418000
CY2019Q1 us-gaap Net Income Loss
NetIncomeLoss
-858000
CY2019Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-888000
CY2020Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-1419000
CY2020Q1 us-gaap Other Assets
OtherAssets
17000
CY2019Q4 us-gaap Other Assets
OtherAssets
33000
CY2019Q1 us-gaap Other General Expense
OtherGeneralExpense
15000
CY2020Q1 us-gaap Other General Expense
OtherGeneralExpense
29000
CY2019Q4 us-gaap Other Liabilities
OtherLiabilities
0
CY2020Q1 us-gaap Other Liabilities
OtherLiabilities
0
CY2019Q1 us-gaap Professional Fees
ProfessionalFees
476000
CY2020Q1 us-gaap Professional Fees
ProfessionalFees
920000
CY2019Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-530389000
CY2020Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-531807000
CY2020Q1 us-gaap Stock Repurchase Program Number Of Shares Authorized To Be Repurchased
StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased
10000000
CY2020Q1 us-gaap Stock Repurchase Program Remaining Number Of Shares Authorized To Be Repurchased
StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased
3774000
CY2020Q1 us-gaap Stockholders Equity
StockholdersEquity
11793000
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
13211000
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
18137000
CY2019Q1 us-gaap Stockholders Equity
StockholdersEquity
17279000
CY2020Q1 us-gaap Treasury Stock Shares
TreasuryStockShares
5672000
CY2019Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
5672000
CY2020Q1 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
0
CY2020Q1 us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
0
CY2020Q1 us-gaap Treasury Stock Value
TreasuryStockValue
5168000
CY2019Q4 us-gaap Treasury Stock Value
TreasuryStockValue
5168000
CY2020Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
40738000
CY2019Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
40738000
CY2020Q1 abcp Shares Acquired Pursuant To Repurchase Plan
SharesAcquiredPursuantToRepurchasePlan
6226000
CY2020Q1 abcp Equity Method Investment Description Of Distribution
EquityMethodInvestmentDescriptionOfDistribution
The JV Agreement and related operating agreements generally provide that all distributable cash shall be distributed as follows: (i) first, 100% to the members in proportion to their percentage interests until Investment LLC has received distributions yielding a 20% internal rate of return as calculated; (ii) second, 100% to the Sponsor as a return of (but not a return on) any additional capital contributions made by the Sponsor on account of manager overruns; and (iii) thereafter, (a) 50% to the members in proportion to their respective percentage interests at the time of such distribution, and (b) 50% to the Sponsor.
CY2014Q1 abcp Percentage Of Distribution On Company S Initial Investment To Be Received Prior To Ceo Receiving Percentage Distribution
PercentageOfDistributionOnCompanySInitialInvestmentToBeReceivedPriorToCEOReceivingPercentageDistribution
1.5
CY2014Q1 abcp Subordinated Participation Interest To Ceo
SubordinatedParticipationInterestToCeo
0.1
CY2013Q1 abcp Amount Paid For Federal Income Taxes Attributable To Alternative Minimum Tax Rate Resulting From Sgw2012 Settlement Agreement
AmountPaidForFederalIncomeTaxesAttributableToAlternativeMinimumTaxRateResultingFromSGW2012SettlementAgreement
501000
CY2020Q1 abcp Deferred Tax Asset Reclassified To Federal Income Tax Receivable
DeferredTaxAssetReclassifiedToFederalIncomeTaxReceivable
5370000
CY2019Q1 abcp Deferred Tax Asset Reclassified To Federal Income Tax Receivable
DeferredTaxAssetReclassifiedToFederalIncomeTaxReceivable
0
CY2019Q1 abcp Proceeds From Litigation Funding Agreement
ProceedsFromLitigationFundingAgreement
470000
CY2020Q1 abcp Proceeds From Litigation Funding Agreement
ProceedsFromLitigationFundingAgreement
0
CY2020Q1 abcp Repayment Of Litigation Funding Agreement
RepaymentOfLitigationFundingAgreement
0
CY2019Q1 abcp Repayment Of Litigation Funding Agreement
RepaymentOfLitigationFundingAgreement
0

Files In Submission

Name View Source Status
0001140361-20-010960-index-headers.html Edgar Link pending
0001140361-20-010960-index.html Edgar Link pending
0001140361-20-010960.txt Edgar Link pending
0001140361-20-010960-xbrl.zip Edgar Link pending
abcp-20200331.xml Edgar Link completed
abcp-20200331.xsd Edgar Link pending
abcp-20200331_cal.xml Edgar Link unprocessable
abcp-20200331_def.xml Edgar Link unprocessable
abcp-20200331_lab.xml Edgar Link unprocessable
abcp-20200331_pre.xml Edgar Link unprocessable
ex31_1.htm Edgar Link pending
ex31_2.htm Edgar Link pending
ex32_1.htm Edgar Link pending
ex32_2.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
form10q.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending